A la une

FULL TEXT PDF:PLOS ONE Journal  

Full text :click here  

PubMed.gov |BMC Public Health .Click here   

The current antibiotic treatment of active drug-susceptible TB, requires administration of a combination therapy for 6 months, including the first-line drugs rifampin (RIF), isoniazid (INH), pyrazinamide (PZA) and ethambutol (EMB) for 2 months, followed by RIF and INH for 4 months [6].According to the poor response to the conventional treatment …